Lucas K Vitzthum

Lucas K Vitzthum

Stanford University

H-index: 14

North America-United States

About Lucas K Vitzthum

Lucas K Vitzthum, With an exceptional h-index of 14 and a recent h-index of 13 (since 2020), a distinguished researcher at Stanford University, specializes in the field of Radiation Oncology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Predicting rapid progression and overall survival in stage II-III pancreatic cancer using a CT-based radiomic signature.

Patterns of recurrence after poor response to neoadjuvant chemotherapy in gastric cancer and the role for adjuvant radiation

First-Year Experience of Stereotactic Body Radiation Therapy/Intensity Modulated Radiation Therapy Treatment Using a Novel Biology-Guided Radiation Therapy Machine

Chest wall pain after single-fraction thoracic stereotactic ablative Radiotherapy: Dosimetric analysis from the iSABR trial

BIOGUIDE-X: A First-in-Human Study of the Performance of Positron Emission Tomography-Guided Radiation Therapy

Volumetric MRI with sparse sampling for MR‐guided 3D motion tracking via sparse prior‐augmented implicit neural representation learning

Lung Cancer Survival Trends in the Veterans Health Administration

Patient Selection and Outcomes for Hypofractionated Accelerated Radiation and Concurrent Chemotherapy for Non–Small-Cell Lung Cancer

Lucas K Vitzthum Information

University

Position

Department of Radiation Oncology

Citations(all)

633

Citations(since 2020)

602

Cited By

150

hIndex(all)

14

hIndex(since 2020)

13

i10Index(all)

21

i10Index(since 2020)

18

Email

University Profile Page

Google Scholar

Lucas K Vitzthum Skills & Research Interests

Radiation Oncology

Top articles of Lucas K Vitzthum

Predicting rapid progression and overall survival in stage II-III pancreatic cancer using a CT-based radiomic signature.

2024/1/20

Patterns of recurrence after poor response to neoadjuvant chemotherapy in gastric cancer and the role for adjuvant radiation

Annals of Surgical Oncology

2024/1

Lucas K Vitzthum
Lucas K Vitzthum

H-Index: 5

First-Year Experience of Stereotactic Body Radiation Therapy/Intensity Modulated Radiation Therapy Treatment Using a Novel Biology-Guided Radiation Therapy Machine

Advances in Radiation Oncology

2024/1/1

Chest wall pain after single-fraction thoracic stereotactic ablative Radiotherapy: Dosimetric analysis from the iSABR trial

Radiotherapy and Oncology

2024/4/27

BIOGUIDE-X: A First-in-Human Study of the Performance of Positron Emission Tomography-Guided Radiation Therapy

International Journal of Radiation Oncology* Biology* Physics

2024/4/1

Volumetric MRI with sparse sampling for MR‐guided 3D motion tracking via sparse prior‐augmented implicit neural representation learning

Medical Physics

2023/11/28

Lung Cancer Survival Trends in the Veterans Health Administration

Clinical Lung Cancer

2024/3/2

Patient Selection and Outcomes for Hypofractionated Accelerated Radiation and Concurrent Chemotherapy for Non–Small-Cell Lung Cancer

Clinical Lung Cancer

2024/3/1

Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer: Protocol for a Bayesian Optimal Phase I/II Trial

Clinical Lung Cancer

2024/3/1

ASO Visual Abstract: Patterns of Recurrence after Poor Response to Neoadjuvant Chemotherapy in Gastric Cancer and the Role for Adjuvant Radiation

Annals of surgical oncology

2024/2

Lucas K Vitzthum
Lucas K Vitzthum

H-Index: 5

Investigating Dosimetry and Imaging Biomarkers for Prediction of Major Adverse Cardiac Events Following Locally Advanced Non-Small Cell Lung Cancer Radiotherapy

International Journal of Radiation Oncology, Biology, Physics

2023/10/1

Unilateral diaphragmatic paralysis after stereotactic ablative radiation therapy to a lung tumor abutting the course of the phrenic nerve

Practical Radiation Oncology

2023/9/1

Mitigation of Intensity Modulated Radiation Therapy and Stereotactic Body Radiation Therapy Treatment Planning Errors on the Novel RefleXion X1 System Using Failure Mode and …

Advances in Radiation Oncology

2023/9/1

Diverging roads in the management of metastatic EGFR mutated non small cell lung cancer: Ablate all, none, or some?

International Journal of Radiation Oncology, Biology, Physics

2023/7/1

Pulmonary Hemorrhage in Patients Treated With Thoracic Stereotactic Ablative Radiotherapy and Antiangiogenic Agents

Journal of Thoracic Oncology

2023/7/1

Maximilian Diehn
Maximilian Diehn

H-Index: 51

Lucas K Vitzthum
Lucas K Vitzthum

H-Index: 5

Adaptive Region-Specific Loss for Improved Medical Image Segmentation

IEEE Transactions on Pattern Analysis and Machine Intelligence

2023/6/26

ASO Author Reflections: A Role for Neoadjuvant Radiation in the Treatment of Locally Advanced Gastric Cancer?

Annals of Surgical Oncology

2023/12

Lucas K Vitzthum
Lucas K Vitzthum

H-Index: 5

MO-0876 BIOGUIDE-X: A First-in-Human Study of the Performance and Safety of Biology-Guided Radiotherapy

Radiotherapy and Oncology

2023/5/1

Risk of developing subsequent primary lung cancer after receiving radiation for breast cancer

JTCVS open

2023/12/1

See List of Professors in Lucas K Vitzthum University(Stanford University)